5.29
-0.75%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Lushang Freda Pharmaceutical Co
Its shares trade on Shanghai under the ticker 600223.SS. It has been listed since 13 January 2000. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.65bn and net income of CN¥187.8m. At that date it held total assets of CN¥5.86bn and shareholders' equity of CN¥4.23bn.
Lushang Freda Pharmaceutical Co., Ltd. engages in the real estate activities. The company is headquartered in Jinan, Shandong. The company went IPO on 2000-01-13. In terms of medicine, the Company is committed to the research and development, production and sales of Chinese patent medicines, chemical medicines, and health foods. Its products cover five fields: orthopedics, gynecology, internal medicine, ophthalmology, and pediatrics. The firm's cosmetic products involve aroma therapy, aroma skin care, aroma health care, aroma health care and other fields. In terms of raw materials, derivative products, and additives, the Company is mainly engaged in the production of hyaluronic acid raw materials.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Real Estate
- Industry
- Real Estate Management & Development
- Listed since
- 13 Jan 2000
- Employees
- 4,648
- Website
- fruida.com.cn ↗
Leadership
Pay as last reported
- Mr. Qingwen JiaChairman of the Board, since 2019
- Mr. Baiqiang XuChief Financial Officer
- Mr. Hongyang ZhangDeputy General Manager, Secretary of the Board
- Ms. Qianqian DouDeputy General Manager
- Mr. Chunming GaoDeputy General Manager
- Mr. Deqiang ZhengDeputy General Manager
- Mr. Zhuo WangDirector
- Mr. Ming ZhouDirector
- Mr. Yuhai SuIndependent DirectorCN¥50,000
- Mr. Desheng ZhuIndependent DirectorCN¥50,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company is headquartered in Jinan, Shandong with 4,648 employees.
- IPO date is 2000-01-13, indicating long market presence.
- Operates in multiple sectors including real estate and pharmaceuticals.
Weaknesses
- Source description incorrectly states the company engages in real estate activities despite sector being listed as Real Estate.
- Source description misrepresents the company's primary activities as pharmaceuticals and cosmetics.
- Inconsistent information between official sector listing and source description.
Opportunities
- Potential to leverage real estate sector for expansion in Jinan, Shandong.
- Opportunity to clarify and align company activities with official sector listing.
- Possible growth in pharmaceutical and cosmetic markets with proper focus.
Threats
- Misinformation in source description may confuse investors and stakeholders.
- Inconsistent sector information could lead to market misperception.
- Risk of reputational damage due to inaccurate public information.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.